SMARTDM2 17+

For outpatient DM2 management

Emory University

Designed for iPad

    • Free

Screenshots

Description

The management of outpatient antihyperglycemic regimens for patients with type 2 diabetes is complicated. This app is designed to synthesize treatment pathway guidelines developed by the American Diabetes Association, the American Association of Clinical Endocrinologists / American College of Endocrinology, and the Emory University Diabetes Council. Based on patient-specific factors that you select, a weighted list of medication options is sorted and presented.

Designed for use by healthcare professionals. We have no relationship with nor has the app been endorsed by the American Diabetes Association, the American Association of Clinical Endocrinologists or the American College of Endocrinology. Results from the app should not be considered medical advice: individual patient factors not accounted for in the app may influence management decisions; medical evidence and guidelines may change ahead of updates to the app; regardless of best efforts, errors may be present in the app. Consult your doctor before making any changes to your medication regimen.

What’s New

Version 13.1.0

Interface updates

App Privacy

The developer, Emory University, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.

Data Not Linked to You

The following data may be collected but it is not linked to your identity:

  • Usage Data
  • Diagnostics

Privacy practices may vary based on, for example, the features you use or your age. Learn More

More By This Developer

Surgical Anatomy of the Lung
Medical
MAG3Renography
Education
EmorySafe
Education
Emory Welcome
Education
eHARTS
Health & Fitness
Emora Chat
Education

You Might Also Like

Remote Patient Monitoring
Medical
DAPT Risk Calculator
Medical
RenalGuard® AKI Calculator
Medical
Card Study
Medical
DoseMed: Pill & Drug Guide
Medical
AI in Clinical Cardiology
Medical